Apyx medical corporation receives fda 510(k) clearance for the use of renuvion® cosmetic technology in dermal resurfacing procedures

Clearwater, fla.--(business wire)--apyx medical corporation (nasdaq:apyx) (the “company”), a maker of medical devices and supplies and the developer of helium plasma technology, marketed and sold as renuvion® and j-plasma® in surgical markets, today announced it has received 510(k) clearance from the u.s. food and drug administration (“fda”) for the use of the renuvion dermal handpiece for specific dermal resurfacing procedures. the renuvion dermal handpiece is indicated for dermatological proc
APYX Ratings Summary
APYX Quant Ranking